Tauroursodeoxycholic Acid-d4 Sodium Salt NEW
Price | $514 | $1540 | $2570 |
Package | 1mg | 5mg | 10mg |
Min. Order: | |
Supply Ability: | 10g |
Update Time: | 2024-10-28 |
Product Details
Product Name: Tauroursodeoxycholic Acid-d4 Sodium Salt | Supply Ability: 10g |
Release date: 2024/10/28 |
Product Introduction
Bioactivity
名稱 | Tauroursodeoxycholic Acid-d4 Sodium Salt |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$0.00/10kgs |
VIP1Y
|
SICHUAN XIELI PHARMACEUTICAL CO.,LTD.
|
2024-12-11 | |
$50.00/50mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2024-11-17 | |
$0.00/1KG |
VIP3Y
|
Hebei Weibang Biotechnology Co., Ltd
|
2024-11-01 | |
$1.00/1PCS |
VIP6Y
|
Hebei Weibang Biotechnology Co., Ltd
|
2024-10-25 | |
$0.00/25kg |
VIP1Y
|
HUBEI VITORCOME PHARMACEUTICAL CO.,LTD
|
2024-09-05 | |
$0.00/1kg |
VIP1Y
|
Hangzhou Hyper Chemicals Limited
|
2024-08-30 | |
$999.00/5kg |
VIP1Y
|
HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD
|
2024-08-20 | |
$10.50/1KG |
VIP4Y
|
Hebei Chuanghai Biotechnology Co,.LTD
|
2024-08-20 | |
$8.80/1kg |
VIP1Y
|
Shandong Deshang Chemical Co., Ltd.
|
2024-08-06 | |
$6.00/1kg |
VIP1Y
|
HebeiShuoshengImportandExportco.,Ltd
|
2024-08-01 |
- Since: 2011-01-07
- Address: 36?Washington?Street, Wellesley?Hills
INQUIRY